| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.2M | +1.1% | +24.7% |
| Cost of Revenue | $13.5M | -0.1% | +21.5% |
| R&D Expense | $11K | -8.3% | -15.4% |
| SG&A Expense | $1.8M | +20.1% | +22.2% |
| Operating Income | -$975K | +7.5% | +41.2% |
| Pre-tax Income | -$975K | +7.5% | +41.2% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.7M | +46.9% | +102.7% |
| Accounts Receivable | $6.1M | -9.9% | -2.9% |
| Current Assets | $9.2M | +4.1% | +10.0% |
| Total Assets | $22.6M | +1.0% | -2.4% |
| Current Liabilities | $7.9M | +3.1% | +3.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.8M | +97.1% | — |
| Capital Expenditures | $112K | +0.0% | — |
| Investing Cash Flow | -$112K | +0.0% | — |
| Free Cash Flow | $1.7M | +110.9% | — |
| — |
| -100.0% |
| Net Income | -$975K | +7.5% | +41.6% |
| EPS (Basic) | -$0.04 | +0.0% | +42.9% |
| $7.9M |
| +3.1% |
| +2.8% |
| Stockholders' Equity | $14.7M | -0.0% | -4.9% |